Core Insights - Illumina (ILMN) is expected to report quarterly earnings of $1.02 per share, reflecting a significant increase of 183.3% year over year, while revenues are forecasted to decline by 5.8% to $1.05 billion [1] Earnings Estimates - The consensus EPS estimate has been revised down by 0.2% in the last 30 days, indicating a reassessment by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts project 'Revenue- Core Illumina- Consumables' to reach $792.14 million, down 2.8% from the previous year [5] - The estimate for 'Revenue- Product revenue- Consumable' is $788.41 million, indicating a decline of 3.3% year over year [5] - 'Revenue- Service and other revenue' is expected to be $157.99 million, reflecting a decrease of 14.6% from the prior year [5] - 'Revenue- Product revenue' is anticipated at $888.52 million, down 4.2% from the previous year [6] - 'Revenue- Core Illumina- Service and other revenue' is projected to be $159.52 million, suggesting a slight increase of 1.6% year over year [6] - 'Revenue- Core Illumina- Total product revenue' is expected to be $886.54 million, indicating a decline of 5.2% year over year [6] - 'Revenue- Product revenue- Instruments' is estimated at $115.79 million, down 3.5% from the year-ago quarter [7] - 'Revenue- Sequencing' is projected to reach $802.27 million, reflecting a significant decline of 19.5% year over year [8] - 'Revenue- Sequencing- Consumables' is expected to be $705.59 million, down 4.3% from the prior year [9] Stock Performance - Illumina shares have increased by 10.8% over the past month, outperforming the Zacks S&P 500 composite, which rose by 3.4% [9]
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics